Skip to main content

Peer Review reports

From: Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats

Original Submission
27 Mar 2019 Submitted Original manuscript
10 Apr 2019 Author responded Author comments - Yuyan Fan
Resubmission - Version 2
10 Apr 2019 Submitted Manuscript version 2
15 May 2019 Reviewed Reviewer Report - Nor AdlinYusoff
18 May 2019 Reviewed Reviewer Report - Peter Achunike Akah
28 Jun 2019 Author responded Author comments - Yuyan Fan
Resubmission - Version 3
28 Jun 2019 Submitted Manuscript version 3
10 Jul 2019 Reviewed Reviewer Report - Abdulsamad Alsalahi
30 Aug 2019 Reviewed Reviewer Report - Badr M. Badr
17 Sep 2019 Author responded Author comments - Yuyan Fan
Resubmission - Version 4
17 Sep 2019 Submitted Manuscript version 4
20 Sep 2019 Reviewed Reviewer Report - Abdulsamad Alsalahi
2 Oct 2019 Reviewed Reviewer Report - Badr M. Badr
10 Oct 2019 Author responded Author comments - Yuyan Fan
Resubmission - Version 5
10 Oct 2019 Submitted Manuscript version 5
16 Oct 2019 Reviewed Reviewer Report - Badr M. Badr
23 Oct 2019 Author responded Author comments - Yuyan Fan
Resubmission - Version 6
23 Oct 2019 Submitted Manuscript version 6
Publishing
23 Oct 2019 Editorially accepted
5 Dec 2019 Article published 10.1186/s12906-019-2728-9

You can find further information about peer review here.

Back to article page